Financhill
Buy
60

GMOV Quote, Financials, Valuation and Earnings

Last price:
$27.63
Seasonality move :
0%
Day range:
$27.58 - $27.70
52-week range:
$21.30 - $27.89
Dividend yield:
1.71%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
22.5K
Avg. volume:
21.2K
1-year change:
14.23%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
GMOV
GMO US Value ETF
-- -- -- -- --
CLCV
Crossmark Large Cap Value ETF
-- -- -- -- --
PRXV
Praxis Impact Large Cap Value ETF
-- -- -- -- --
STXV
Strive 1000 Value ETF
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
GMOV
GMO US Value ETF
$27.65 -- -- -- $0.15 1.71% --
CLCV
Crossmark Large Cap Value ETF
$26.55 -- -- -- $0.11 0% --
PRXV
Praxis Impact Large Cap Value ETF
$30.37 -- -- -- $0.13 0% --
STXV
Strive 1000 Value ETF
$33.36 -- -- -- $0.21 3.02% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
GMOV
GMO US Value ETF
-- 0.722 -- --
CLCV
Crossmark Large Cap Value ETF
-- 0.000 -- --
PRXV
Praxis Impact Large Cap Value ETF
-- 0.000 -- --
STXV
Strive 1000 Value ETF
-- 0.664 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
GMOV
GMO US Value ETF
-- -- -- -- -- --
CLCV
Crossmark Large Cap Value ETF
-- -- -- -- -- --
PRXV
Praxis Impact Large Cap Value ETF
-- -- -- -- -- --
STXV
Strive 1000 Value ETF
-- -- -- -- -- --

GMO US Value ETF vs. Competitors

  • Which has Higher Returns GMOV or CLCV?

    Crossmark Large Cap Value ETF has a net margin of -- compared to GMO US Value ETF's net margin of --. GMO US Value ETF's return on equity of -- beat Crossmark Large Cap Value ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    GMOV
    GMO US Value ETF
    -- -- --
    CLCV
    Crossmark Large Cap Value ETF
    -- -- --
  • What do Analysts Say About GMOV or CLCV?

    GMO US Value ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Crossmark Large Cap Value ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that GMO US Value ETF has higher upside potential than Crossmark Large Cap Value ETF, analysts believe GMO US Value ETF is more attractive than Crossmark Large Cap Value ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    GMOV
    GMO US Value ETF
    0 0 0
    CLCV
    Crossmark Large Cap Value ETF
    0 0 0
  • Is GMOV or CLCV More Risky?

    GMO US Value ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Crossmark Large Cap Value ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock GMOV or CLCV?

    GMO US Value ETF has a quarterly dividend of $0.15 per share corresponding to a yield of 1.71%. Crossmark Large Cap Value ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.11 per share. GMO US Value ETF pays -- of its earnings as a dividend. Crossmark Large Cap Value ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios GMOV or CLCV?

    GMO US Value ETF quarterly revenues are --, which are smaller than Crossmark Large Cap Value ETF quarterly revenues of --. GMO US Value ETF's net income of -- is lower than Crossmark Large Cap Value ETF's net income of --. Notably, GMO US Value ETF's price-to-earnings ratio is -- while Crossmark Large Cap Value ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GMO US Value ETF is -- versus -- for Crossmark Large Cap Value ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GMOV
    GMO US Value ETF
    -- -- -- --
    CLCV
    Crossmark Large Cap Value ETF
    -- -- -- --
  • Which has Higher Returns GMOV or PRXV?

    Praxis Impact Large Cap Value ETF has a net margin of -- compared to GMO US Value ETF's net margin of --. GMO US Value ETF's return on equity of -- beat Praxis Impact Large Cap Value ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    GMOV
    GMO US Value ETF
    -- -- --
    PRXV
    Praxis Impact Large Cap Value ETF
    -- -- --
  • What do Analysts Say About GMOV or PRXV?

    GMO US Value ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Praxis Impact Large Cap Value ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that GMO US Value ETF has higher upside potential than Praxis Impact Large Cap Value ETF, analysts believe GMO US Value ETF is more attractive than Praxis Impact Large Cap Value ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    GMOV
    GMO US Value ETF
    0 0 0
    PRXV
    Praxis Impact Large Cap Value ETF
    0 0 0
  • Is GMOV or PRXV More Risky?

    GMO US Value ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Praxis Impact Large Cap Value ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock GMOV or PRXV?

    GMO US Value ETF has a quarterly dividend of $0.15 per share corresponding to a yield of 1.71%. Praxis Impact Large Cap Value ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.13 per share. GMO US Value ETF pays -- of its earnings as a dividend. Praxis Impact Large Cap Value ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios GMOV or PRXV?

    GMO US Value ETF quarterly revenues are --, which are smaller than Praxis Impact Large Cap Value ETF quarterly revenues of --. GMO US Value ETF's net income of -- is lower than Praxis Impact Large Cap Value ETF's net income of --. Notably, GMO US Value ETF's price-to-earnings ratio is -- while Praxis Impact Large Cap Value ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GMO US Value ETF is -- versus -- for Praxis Impact Large Cap Value ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GMOV
    GMO US Value ETF
    -- -- -- --
    PRXV
    Praxis Impact Large Cap Value ETF
    -- -- -- --
  • Which has Higher Returns GMOV or STXV?

    Strive 1000 Value ETF has a net margin of -- compared to GMO US Value ETF's net margin of --. GMO US Value ETF's return on equity of -- beat Strive 1000 Value ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    GMOV
    GMO US Value ETF
    -- -- --
    STXV
    Strive 1000 Value ETF
    -- -- --
  • What do Analysts Say About GMOV or STXV?

    GMO US Value ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Strive 1000 Value ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that GMO US Value ETF has higher upside potential than Strive 1000 Value ETF, analysts believe GMO US Value ETF is more attractive than Strive 1000 Value ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    GMOV
    GMO US Value ETF
    0 0 0
    STXV
    Strive 1000 Value ETF
    0 0 0
  • Is GMOV or STXV More Risky?

    GMO US Value ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Strive 1000 Value ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock GMOV or STXV?

    GMO US Value ETF has a quarterly dividend of $0.15 per share corresponding to a yield of 1.71%. Strive 1000 Value ETF offers a yield of 3.02% to investors and pays a quarterly dividend of $0.21 per share. GMO US Value ETF pays -- of its earnings as a dividend. Strive 1000 Value ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios GMOV or STXV?

    GMO US Value ETF quarterly revenues are --, which are smaller than Strive 1000 Value ETF quarterly revenues of --. GMO US Value ETF's net income of -- is lower than Strive 1000 Value ETF's net income of --. Notably, GMO US Value ETF's price-to-earnings ratio is -- while Strive 1000 Value ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GMO US Value ETF is -- versus -- for Strive 1000 Value ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GMOV
    GMO US Value ETF
    -- -- -- --
    STXV
    Strive 1000 Value ETF
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 20

Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.

Buy
54
BMRN alert for Dec 20

BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.

Buy
82
RKLB alert for Dec 20

Rocket Lab Corp. [RKLB] is up 17.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock